✦ LIBER ✦

Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study

✍ Scribed by Beny Charbit; Arnaud Rosier; Diane Bollens; Franck Boccara; Pierre-Yves Boelle; Afef Koubaa; Pierre-Marie Girard; Christian Funck-Brentano

Book ID: 108642229
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 563 KB
Volume: 67
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2008.03332.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HIV protease inhibitors influence the pr

HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study : HIV-Protease-Inhibitoren beeinflussen die Häufigkeit oraler Candidose bei HIV-Patienten. Eine Zweijahresstudie

✍ L. Hoeg; E. Thoma-Greber; M. Röcken; H. C. Korting 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Risk factors and correlates for anemia i

Risk factors and correlates for anemia in HIV treatment-naïve infected patients: a cross-sectional analytical study

✍ José A Mata-Marín; Jesús E Gaytán-Martínez; Rosa E Martínez-Martínez; Carla I Ar 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 278 KB

Influence of Antiretroviral Therapy on O

Influence of Antiretroviral Therapy on Oxidative Stress and Cardiovascular Risk: A Prospective Cross-Sectional Study in HIV-Infected Patients

✍ Mar Masiá; Sergio Padilla; Enrique Bernal; Maria V. Almenar; Juan Molina; Ildefo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 580 KB

No relationship between high nevirapine

No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors

✍ Eric Dailly; Eric Billaud; Véronique Reliquet; Sébastien Breurec; Philippe Perré 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 221 KB

Management of drug-to-drug interactions

Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients

✍ Martin Vogel; Esther Voigt; Hans-Christoph Michaelis; Thomas Sudhop; Martin Wolf 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

Highly active antiretroviral therapy (HAART) has improved the life expectancy of HIV-infected patients, allowing orthotopic liver transplantation as a reasonable treatment option for selected patients with terminal liver disease. Both non-nucleoside reverse transcriptase inhibitors and protease inhi

The Protease Inhibitor Transfer Study (P

The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load

✍ M Bickel; V Rickerts; C Stephan; V Jacobi; C Rottmann; B Dauer; A Carlebach; A T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB